Mathura (Uttar Pradesh) [India], October 4: Sanskriti University, Mathura, recently celebrated two days of festivity and reflection, bringing together the dual essence of its campus -- youthful energy and deep-rooted tradition. The celebrations began with the Fresher's Fiesta 2025 on Septemb
The Ministry of External Affairs stated on Friday that India is closely monitoring the impact of US President Donald Trump's announcement to impose tariffs of up to 100% on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.
European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI).
India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA).
Americans will be the first to be affected, said Niranjan Hiranandani, Founder and Chairman of the Hiranandani Group on Friday, in response to U.S. President Donald J. Trump's announcement of a 100 per cent tariff on branded and patented pharmaceutical products.
The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. According to a government release, drug and pharmaceutical exports increased by 6.94 per cent from USD 2.35
In a post on Truth Social, President Trump wrote, "Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. 'IS BUILDING' will be defined as 'breaking
Agnikul already holds a US patent for single-piece 3D-printed rocket engines. The new facility will allow the company to print engines measuring one metre and deliver seven times the thrust of its earlier designs, the company said. With this facility that's commissioned, the company can manu
Israeli ag-biotech firm PlantArcBio announced Thursday that it has secured patents in the United States and South Korea for its DIPPER platform, which optimises gene-editing processes in crops.
New Delhi [India], September 13: Lynkit, an award-winning supply chain automation company, has announced the grant of its second patent for its Delivery Assistance System and Method. This innovation introduces a fully native solution for route and load optimisation, designed and developed en
Thane (Maharashtra) [India], September 13: Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA:IN) (Reuters: FERM.BO), India's leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for global markets, today announced that the Indian Patent Office has for
Scottsdale (Arizona) [US], September 11: Imaging Endpoints (IE), the global leader in Imaging CRO technologies and services for oncology trials, announced the filing of a provisional patent application for its revolutionary AI enhanced Imaging Review Charter (IRC) system. This innovative AIR